12:00 AM
Feb 13, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Afectair regulatory update

FDA approved Discovery Labs' Afectair patient interface technology for the delivery of aerosolized medications to critical-care patients requiring ventilator...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >